In vivo experimental models account for higher complexity than in vitro preclinical settings in cancer

Lung cancer is the leading cause of cancer death worldwide. There is no current treatment able to efficiently treat the disease as the lung cancer is often diagnosed at an advanced stage. Furthermore, lung cancer cells are often resistant or acquire resistance to the treatment.